The Asia Pacific Veterinary Dermatology Drugs Market would witness market growth of 9.5% CAGR during the forecast period (2021-2027).
The veterinary profession has witnessed a dramatic transition in the last couple of years. A number of different demographic and socioeconomic factors are responsible for these transitions, including livestock, social attitudes, food production, higher adoption of companion animals, the fast pace of urbanization, and these are anticipated to drive the growth of the veterinary dermatology drugs market during the forecasting period. Atopic dermatitis is the main cause of itching in companion animals. Atopy is a genetically acquired predisposition to get allergic to airborne pollens like grass, weeds, house dust, trees, molds, and dust. In companion animal dogs, cats’ atopic dermatitis is the leading cause of biting, chewing, rubbing, and chronic skin & ear infections.
Factors like surging medical & diagnostic capabilities for companion animals and growing ownership of companion animals would support the growth & demand for veterinary dermatology drugs. In addition, the growth of the overall market is further driven by the major strategies adopted by market players in the industry such as partnerships, collaborations, and mergers & acquisitions. The application of veterinary dermatology drugs is expected to increase due to the growing longevity of pet animals because of the enhancements in diagnostics, higher significance placed on wellness and prevention of diseases by veterinarians, and better nutrition.
The Asia-Pacific, led by China, India, Japan, and South Korea is as one of the key markets around the world. The massive demand for veterinary dermatology drugs is directly proportional to the growth of the regional market. The developing countries of the region such as India have witnessed the unbridled spread of misinformation from the immunity to infection of the pets; some households began to leave their pets. This compelled the companies operating in the pet food market to introduce various awareness campaigns to dismiss the rumors.
Due to the panic purchasing of pet food and drugs, a massive supply and demand gap has been created in the market. In addition, the veterinary dermatology drugs market in the region was incapable to fulfill the demand because of the disruptions in the supply chain and declined logistic services. Hence, the growth of the regional market is expected to be fueled by the rapid urbanization and infrastructure changes in the last few years.
The China market dominated the Asia Pacific Allergic Infections Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $310.2 million by 2027. The Japan market is showcasing a CAGR of 9% during (2021 - 2027). Additionally, The India market is poised to grow at a CAGR of 10.5% during (2021 - 2027).
Based on Route of Administration, the market is segmented into Topical, Injectable and Oral. Based on Distribution Channel, the market is segmented into Retail, Hospital Pharmacies and Online. Based on Drug Indication, the market is segmented into Parasitic Infections, Allergic Infections and Other Indications. Based on Animal Type, the market is segmented into Companion Animal and Livestock Animal. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Veterinary Dermatology Drugs Market is Projected to reach USD 13.6 Billion by 2027, at a CAGR of 8.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Elanco Animal Health, Inc., Zoetis, Inc., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Vetoquinol SA (Soparfin SCA), Virbac, Bioibérica, S.A.U., Bimeda, Inc., and Ceva Santé Animale.
Scope of the Study
Market Segments Covered in the Report:
By Route of Administration
By Distribution Channel
- Retail
- Hospital Pharmacies
- Online
By Drug Indication
- Parasitic Infections
- Allergic Infections
- Other Indications
By Animal Type
- Companion Animal
- Livestock Animal
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Merck Group
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Vetoquinol SA (Soparfin SCA)
- Virbac
- Bioibérica, S.A.U.
- Bimeda, Inc.
- Ceva Santé Animale
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Veterinary Dermatology Drugs Market, by Route of Administration
1.4.2 Asia Pacific Veterinary Dermatology Drugs Market, by Distribution Channel
1.4.3 Asia Pacific Veterinary Dermatology Drugs Market, by Drug Indication
1.4.4 Asia Pacific Veterinary Dermatology Drugs Market, by Animal Type
1.4.5 Asia Pacific Veterinary Dermatology Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Veterinary Dermatology Drugs Market by Route of Administration
3.1 Asia Pacific Topical Market by Country
3.2 Asia Pacific Injectable Market by Country
3.3 Asia Pacific Oral Market by Country
Chapter 4. Asia Pacific Veterinary Dermatology Drugs Market by Distribution Channel
4.1 Asia Pacific Retail Market by Country
4.2 Asia Pacific Hospital Pharmacies Market by Country
4.3 Asia Pacific Online Market by Country
Chapter 5. Asia Pacific Veterinary Dermatology Drugs Market by Drug Indication
5.1 Asia Pacific Parasitic Infections Market by Country
5.2 Asia Pacific Allergic Infections Market by Country
5.3 Asia Pacific Other Indications Market by Region
Chapter 6. Asia Pacific Veterinary Dermatology Drugs Market by Animal Type
6.1 Asia Pacific Companion Animal Market by Country
6.2 Asia Pacific Livestock Animal Market by Country
Chapter 7. Asia Pacific Veterinary Dermatology Drugs Market by Region
7.1 China Veterinary Dermatology Drugs Market
7.1.1 China Veterinary Dermatology Drugs Market by Route of Administration
7.1.2 China Veterinary Dermatology Drugs Market by Distribution Channel
7.1.3 China Veterinary Dermatology Drugs Market by Drug Indication
7.1.4 China Veterinary Dermatology Drugs Market by Animal Type
7.2 Japan Veterinary Dermatology Drugs Market
7.2.1 Japan Veterinary Dermatology Drugs Market by Route of Administration
7.2.2 Japan Veterinary Dermatology Drugs Market by Distribution Channel
7.2.3 Japan Veterinary Dermatology Drugs Market by Drug Indication
7.2.4 Japan Veterinary Dermatology Drugs Market by Animal Type
7.3 India Veterinary Dermatology Drugs Market
7.3.1 India Veterinary Dermatology Drugs Market by Route of Administration
7.3.2 India Veterinary Dermatology Drugs Market by Distribution Channel
7.3.3 India Veterinary Dermatology Drugs Market by Drug Indication
7.3.4 India Veterinary Dermatology Drugs Market by Animal Type
7.4 South Korea Veterinary Dermatology Drugs Market
7.4.1 South Korea Veterinary Dermatology Drugs Market by Route of Administration
7.4.2 South Korea Veterinary Dermatology Drugs Market by Distribution Channel
7.4.3 South Korea Veterinary Dermatology Drugs Market by Drug Indication
7.4.4 South Korea Veterinary Dermatology Drugs Market by Animal Type
7.5 Singapore Veterinary Dermatology Drugs Market
7.5.1 Singapore Veterinary Dermatology Drugs Market by Route of Administration
7.5.2 Singapore Veterinary Dermatology Drugs Market by Distribution Channel
7.5.3 Singapore Veterinary Dermatology Drugs Market by Drug Indication
7.5.4 Singapore Veterinary Dermatology Drugs Market by Animal Type
7.6 Malaysia Veterinary Dermatology Drugs Market
7.6.1 Malaysia Veterinary Dermatology Drugs Market by Route of Administration
7.6.2 Malaysia Veterinary Dermatology Drugs Market by Distribution Channel
7.6.3 Malaysia Veterinary Dermatology Drugs Market by Drug Indication
7.6.4 Malaysia Veterinary Dermatology Drugs Market by Animal Type
7.7 Rest of Asia Pacific Veterinary Dermatology Drugs Market
7.7.1 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Route of Administration
7.7.2 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Distribution Channel
7.7.3 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Drug Indication
7.7.4 Rest of Asia Pacific Veterinary Dermatology Drugs Market by Animal Type
Chapter 8. Company Profiles
8.1 Merck Group
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.2 Elanco Animal Health, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.5.2 Product Launches and product Expansions:
8.3 Zoetis, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Approvals and Trials:
8.4 Eli Lilly and Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisitions and Mergers:
8.5 Boehringer Ingelheim International Gmbh
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.6 Vetoquinol SA (Soparfin SCA)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Recent strategies and developments:
8.6.3.1 Partnerships, Collaborations, and Agreements:
8.6.3.2 Acquisitions and Mergers:
8.7 Virbac
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.8 Bioibérica, S.A.U.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Bimeda, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Acquisitions and Mergers:
8.9.2.2 Product Launches and Product Expansions:
8.10. Ceva Santé Animale
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Product Launches and Product Expansions:
TABLE 1 Europe Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 2 Europe Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 3 Europe Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 4 Europe Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 5 Europe Topical Market by Country, 2017 - 2020, USD Million
TABLE 6 Europe Topical Market by Country, 2021 - 2027, USD Million
TABLE 7 Europe Injectable Market by Country, 2017 - 2020, USD Million
TABLE 8 Europe Injectable Market by Country, 2021 - 2027, USD Million
TABLE 9 Europe Oral Market by Country, 2017 - 2020, USD Million
TABLE 10 Europe Oral Market by Country, 2021 - 2027, USD Million
TABLE 11 Europe Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 12 Europe Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 13 Europe Retail Market by Country, 2017 - 2020, USD Million
TABLE 14 Europe Retail Market by Country, 2021 - 2027, USD Million
TABLE 15 Europe Hospital Pharmacies Market by Country, 2017 - 2020, USD Million
TABLE 16 Europe Hospital Pharmacies Market by Country, 2021 - 2027, USD Million
TABLE 17 Europe Online Market by Country, 2017 - 2020, USD Million
TABLE 18 Europe Online Market by Country, 2021 - 2027, USD Million
TABLE 19 Europe Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 20 Europe Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 21 Europe Parasitic Infections Market by Region, 2017 - 2020, USD Million
TABLE 22 Europe Parasitic Infections Market by Region, 2021 - 2027, USD Million
TABLE 23 Europe Allergic Infections Market by Country, 2017 - 2020, USD Million
TABLE 24 Europe Allergic Infections Market by Country, 2021 - 2027, USD Million
TABLE 25 Europe Other Indications Market by Region, 2017 - 2020, USD Million
TABLE 26 Europe Other Indications Market by Region, 2021 - 2027, USD Million
TABLE 27 Europe Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 28 Europe Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 29 Europe Companion Animal Market by Country, 2017 - 2020, USD Million
TABLE 30 Europe Companion Animal Market by Country, 2021 - 2027, USD Million
TABLE 31 Europe Livestock Animal Market by Country, 2017 - 2020, USD Million
TABLE 32 Europe Livestock Animal Market by Country, 2021 - 2027, USD Million
TABLE 33 Europe Veterinary Dermatology Drugs Market by Region, 2017 - 2020, USD Million
TABLE 34 Europe Veterinary Dermatology Drugs Market by Region, 2021 - 2027, USD Million
TABLE 35 Germany Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 36 Germany Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 37 Germany Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 38 Germany Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 39 Germany Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 40 Germany Veterinary Dermatology Drugs Market by Distribution Channel
TABLE 41 Germany Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 42 Germany Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 43 Germany Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 44 Germany Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 45 UK Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 46 UK Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 47 UK Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 48 UK Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 49 UK Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 50 UK Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 51 UK Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 52 UK Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 53 UK Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 54 UK Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 55 France Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 56 France Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 57 France Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 58 France Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 59 France Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 60 France Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 61 France Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 62 France Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 63 France Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 64 France Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 65 Russia Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 66 Russia Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 67 Russia Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 68 Russia Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 69 Russia Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 70 Russia Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 71 Russia Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 72 Russia Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 73 Russia Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 74 Russia Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 75 Spain Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 76 Spain Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 77 Spain Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 78 Spain Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 79 Spain Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 80 Spain Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 81 Spain Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 82 Spain Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 83 Spain Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 84 Spain Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 85 Italy Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 86 Italy Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 87 Italy Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 88 Italy Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 89 Italy Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 90 Italy Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 91 Italy Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 92 Italy Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 93 Italy Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 94 Italy Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 95 Rest of Europe Veterinary Dermatology Drugs Market, 2017 - 2020, USD Million
TABLE 96 Rest of Europe Veterinary Dermatology Drugs Market, 2021 - 2027, USD Million
TABLE 97 Rest of Europe Veterinary Dermatology Drugs Market by Route of Administration, 2017 - 2020, USD Million
TABLE 98 Rest of Europe Veterinary Dermatology Drugs Market by Route of Administration, 2021 - 2027, USD Million
TABLE 99 Rest of Europe Veterinary Dermatology Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 100 Rest of Europe Veterinary Dermatology Drugs Market by Distribution Channel, 2021 - 2027, USD Million
TABLE 101 Rest of Europe Veterinary Dermatology Drugs Market by Drug Indication, 2017 - 2020, USD Million
TABLE 102 Rest of Europe Veterinary Dermatology Drugs Market by Drug Indication, 2021 - 2027, USD Million
TABLE 103 Rest of Europe Veterinary Dermatology Drugs Market by Animal Type, 2017 - 2020, USD Million
TABLE 104 Rest of Europe Veterinary Dermatology Drugs Market by Animal Type, 2021 - 2027, USD Million
TABLE 105 key Information – Merck Group
TABLE 106 Key information – Elanco Animal Health, Inc.
TABLE 107 Key Information – Zoetis, Inc.
TABLE 108 Key Information – Eli Lilly and Company
TABLE 109 Key Information – Boehringer Ingelheim International GmbH
TABLE 110 Key Information – Vetoquinol SA
TABLE 111 Key Information – Virbac
TABLE 112 Key Information – Bioibérica, S.A.U.
TABLE 113 Key Information – Bimeda, Inc.
TABLE 114 Key Information – Ceva Santé Animale
List of Figures
FIG 1 Methodology for the research
FIG 1 Recent strategies and developments: Bioibérica, S.A.U.
FIG 2 Recent strategies and developments: Bimeda, Inc.